Sort
141,003 grants matching “cytokine”
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$976,018Justin Rodney Savage · Glycomira, Llc · R44 · FY2022 · AI
Trimer Production and Immunogenicity Testing
$975,915William C Olson · Progenics Pharmaceuticals, Inc. · P01 · FY2009 · AI
T-Cell Vaccine-A Clinical Trail for Progressive MS
$975,900University Of Southern California · R01 · FY2003 · NS
Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
$975,742Wendy Cozen · University Of California-Irvine · R01 · FY2021 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$975,704Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Human Life Course and the Biodemography of Aging
$975,411Michael Douglas Gurven · University Of California Santa Barbara · R01 · FY2014 · AG
University of Michigan Center for Gastrointestinal Research
$975,352Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2018 · DK
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity
$975,215Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2023 · DK
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity
$975,215Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2024 · DK
The UIUC Neuroproteomics Center on Cell-Cell Signaling
$975,151Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2007 · DA
Improving Functioning in Peripheral Arterial Disease
$975,127Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2006 · HL
Trimer Production and Immunogenicity Testing
$975,077William C Olson · Progenics Pharmaceuticals, Inc. · P01 · FY2010 · AI
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$974,959Yen Tun Wang · Curebiotech, Inc. · R44 · FY2020 · CA
Physical Activity, Energy Balance, and Cancer
$974,890Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
$974,853Jay L Rothstein · Immunext, Inc. · R44 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$974,750Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI
Genetic &Clinical Risk for Human SLE Nephritis
$974,620Ohio State University · P01 · FY2005 · DK
GENETIC AND IMMUNOLOGIC ASPECTS OF PERIODONTAL DISEASES
$974,515Virginia Commonwealth University · U19 · FY2001 · DE
Immune reconstitution following autologous and allogeneic stem cell transplant
$974,472Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
A Novel Recombinant Protein for Mitigating Acute Radiation Injury
$974,383Wayne Chaung · Therasource, Llc · R44 · FY2021 · AI
A Novel Recombinant Protein for Mitigating Acute Radiation Injury
$974,383Wayne Chaung · Therasource, Llc · R44 · FY2020 · AI
A Novel Recombinant Protein for Mitigating Acute Radiation Injury
$974,383Wayne Chaung · Therasource, Llc · R44 · FY2022 · AI
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$974,208Jing Zhou · Isoplexis, Inc. · R44 · FY2017 · CA
A Phase I Study of Mistletoe Extract on PK, PD, and Safety of Gemcitabine in CA
$974,000Patrick J Mansky · Complementary & Integrative Health · Z01 · FY2007 · AT
Pathogenic differences between Cryptococcus neoformans and C. gattii
$973,984Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI